December 2022
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference discussed the next steps for genomics in the UK.
It was an opportunity to explore the future of genomic transformation in the NHS, looking at screening and personalised medicine, workforce education and training, and the options for pharmacogenomics in clinical practice.
Following the shared commitments across the UK nations for implementing Genome UK 2022 to 2025, delegates also discussed opportunities for UK-wide collaboration in research and development of novel treatments.
Key areas for discussion included:
- opportunities: latest thinking on the use and potential of genomics to improve public health and develop personalised medicine - next steps for data use - genomics in screening
- R&D: priorities for supporting innovation and collaborating on evaluation at UK level - systems to support innovative therapies - integration of health and genomic data in research
- pathogen genomic sequencing: taking forward lessons from systems used during the pandemic - the next steps for embedding capacity and scalability within the system
- implementation: the way forward for genomic transformation in the NHS - ensuring rapid implementation of new science, research and innovation in genomics - embedding genomics in the NHS
- pharmacogenomics: its role in drug discovery and prescribing - what has been learned from early developments - patient engagement - options for scaling up use in clinical practice
- collaboration and investment across the UK: key considerations for data-sharing and monitoring
- developing genomic healthcare services: improving pathways - priorities for workforce education - reducing regional variation in implementation - opportunities for patient engagement
We are pleased to have been able to include keynote sessions with Professor Dame Sue Hill, Chief Scientific Officer for England and Senior Responsible Officer for Genomics; NHS England and NHS Improvement; Dr Richard Scott, Chief Medical Officer, Genomics England; Consultant, Great Ormond Street Hospital for Children; and Honorary Senior Lecturer, Institute of Child Health, University College London; Dr Rob Orford, Chief Scientific Adviser for Health in Wales, Welsh Government; Professor Dyfrig Hughes, Professor of Pharmacoeconomics and Co-director, Centre of Health Economics and Medicines Evaluation, Bangor University; and Dr Charlotte Jennings, Research Fellow in Digital Pathology, National Pathology Imaging Cooperative and Leeds Teaching Hospitals NHS Trust.
The conference was an opportunity for stakeholders to consider the issues alongside key policy officials who attended from Defra; the Department of Health, NI; DHSC; MHRA; OLS; The Scottish Government; and the Welsh Government.
